Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2022-09-09 Share Issue/Capital Cha…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
220909 - Disposals of own shares_ENG.pdf
Share Issue/Capital Change Classification · 1% confidence The document is titled 'Disposal of own shares' and explicitly states that UCB SA/NV has delivered for free a total of 742 UCB shares OTC to personnel in accordance with LTI plans. This action—the delivery/disposal of own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The document is a short, regulated information press release announcing this specific transaction, making the code POS the most accurate fit.
2022-09-09 English
220909 - Aliénation d'actions propres_FR.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Aliénation d'actions propres" (Alienation of own shares) and the content explicitly states that UCB SA/NV delivered 742 UCB shares OTC on September 5, 2022, as part of Long-Term Incentive (LTI) plans. This action directly relates to the company managing its own share capital by issuing shares to employees, which falls under the category of transactions in own shares or share issuance. The definition for 'Transaction in Own Shares' (POS) is 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. This is a direct report of such a transaction, not an announcement of a report (RPA) or a general regulatory filing (RNS). The document is short, but it contains the substantive details of the transaction itself, making POS the most accurate classification over RPA/RNS.
2022-09-09 French
220909 - Vervreemding van eigen aandelen_NL.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Vervreemding van eigen aandelen" (Disposal of own shares) and the content explicitly details the delivery of 742 UCB shares to employees as part of long-term incentive (LTI) plans on September 5, 2022. This action—the company dealing in its own shares (repurchase or issuance/delivery related to compensation)—directly corresponds to the definition of 'Transaction in Own Shares'. The filing code POS is the most appropriate match.
2022-09-09 Dutch
PR 190822 - ENG.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Disposal of own shares" and details a transaction where UCB disposed of 2,500 of its own shares OTC following stock option exercises related to its Long-Term Incentive Program. This directly relates to the company buying back or issuing its own shares. According to the definitions, 'Transaction in Own Shares (Code: POS)' covers the report of the company buying back or selling its own shares. The document is a formal announcement of this specific transaction, not just an announcement of a report's publication.
2022-08-19 English
PR190822 - FR.pdf
Share Issue/Capital Change Classification · 1% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and explicitly states it is an "Information réglementée" (Regulated Information) dated August 19, 2022. The content details the disposal (alienation/sale) of UCB shares following the exercise of options by employees, which falls under the category of the company buying back or selling its own shares (share repurchase/issuance). This directly corresponds to the definition for Transaction in Own Shares (Code: POS). It is not an Earnings Release (ER), Interim Report (IR), or a general Regulatory Filing (RNS), as it concerns a specific corporate action related to treasury stock/employee compensation fulfillment.
2022-08-19 French
PR 190822 - NL.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details a transaction where UCB disposed of company shares (2,500 shares) following the exercise of options by employees under long-term incentive plans. This action—the company dealing in its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The filing code for this is POS. The document is a formal announcement (Gereglementeerde informatie) detailing the transaction, not just an announcement of a report.
2022-08-19 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.